Home Cart 0 Sign in  
X

[ CAS No. 42142-52-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 42142-52-9
Chemical Structure| 42142-52-9
Chemical Structure| 42142-52-9
Structure of 42142-52-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 42142-52-9 ]

Related Doc. of [ 42142-52-9 ]

Alternatived Products of [ 42142-52-9 ]

Product Details of [ 42142-52-9 ]

CAS No. :42142-52-9 MDL No. :MFCD00674078
Formula : C10H15NO Boiling Point : -
Linear Structure Formula :- InChI Key :XXSDCGNHLFVSET-UHFFFAOYSA-N
M.W : 165.23 Pubchem ID :2733989
Synonyms :
Chemical Name :3-(Methylamino)-1-phenylpropan-1-ol

Calculated chemistry of [ 42142-52-9 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.4
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 49.79
TPSA : 32.26 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.6 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.11
Log Po/w (XLOGP3) : 1.0
Log Po/w (WLOGP) : 1.01
Log Po/w (MLOGP) : 1.56
Log Po/w (SILICOS-IT) : 1.74
Consensus Log Po/w : 1.48

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.6
Solubility : 4.15 mg/ml ; 0.0251 mol/l
Class : Very soluble
Log S (Ali) : -1.27
Solubility : 8.95 mg/ml ; 0.0542 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.11
Solubility : 0.128 mg/ml ; 0.000776 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.48

Safety of [ 42142-52-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 42142-52-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 42142-52-9 ]
  • Downstream synthetic route of [ 42142-52-9 ]

[ 42142-52-9 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 2538-50-3 ]
  • [ 42142-52-9 ]
YieldReaction ConditionsOperation in experiment
90% With sodium tetrahydroborate In methanol at 20℃; for 1 h; The 2a (0.5mmol) was dissolved in 0.5mL of methanol,At room temperature was slowly added NaBH 4 (2.0mmol),Mixture was stirred at room temperature 1h.Added 2mL saturated NH 4Cl solution.The solvent was removed by distillation under reduced pressure.The residue was added 5mLNaOH (1N),With 5mLCH 2Cl 2 and extracted four times.The organic phase was collected and dried over anhydrous sodium sulfate,And concentrated to give the crude product.The crude product after column chromatography product 2b.Yield: 90percent.
Reference: [1] Patent: CN103992236, 2016, B, . Location in patent: Paragraph 0051;0054; 0055
[2] Angewandte Chemie - International Edition, 2005, vol. 44, # 11, p. 1687 - 1689
  • 2
  • [ 877-50-9 ]
  • [ 42142-52-9 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: With sodium tetrahydroborate In acetic acid at 5 - 10℃; for 3.5 h;
Example 2 Reduction of 3-(Methylamino)-1-phenyl-2-propen-1-one with NaBH4 in HOAc. [0031] Acetic acid was used instead of methanol in combination with sodium borohydride under mild conditions for the reduction of 3-(methylamino)-1-phenyl-2-propen-1-one. Sodium borohydride (6 equivalents) was slowly added to a 0.25 M solution of 3-(methylamino)-1-phenyl-2-propen-1-one (Formula 3), in glacial acetic acid at 5-10° C. after stirring for 3 hours at room temperature followed by the usual work-up, the target aminoalcohol was isolated with a 77percent yield (Table 1, entry 1). The effectiveness of this method may be due to the enhanced activity of both carbonyl and azomethyne groups under acidic conditions. [0032] In a particular example, NaBH4 (800 mg, 21.0 mmol) was added in portions to a vigorously stirred solution of 3-(methylamino)-1-phenyl-2-propen-1-one (600 mg, 3.7 mmol) in glacial HOAc (15 mL) over a period of 30 min at 5-10° C. The reaction mixture was stirred for another 30 min at the same temperature, and then for 3 hours at room temperature. Work-up was done using 4 M aqueous sodium hydroxide (60 mL) that was added dropwise under water/ice bath cooling (the pH of the resulting solution was about 12). The resulting mixture was extracted with EtOAc (3.x.70 mL), washed with H2O (50 mL), and dried (Na2SO4). Evaporation of the solvent under reduced pressure gave 470 mg (77percent) of 2 as yellow oil. [0033] A similar transformation was also achieved by the use of a mixture of sodium metal (6 equiv.), isopropanol and tetrahydrofuran (Table 1, entry 2) under the conditions of the electron transfer reduction reported recently for a similar reaction of a series of enaminones. Unfortunately, the yield was only 55percent; and the reduction product contained some impurities that were difficult to remove. [TABLE-US-00001] TABLE 1 Reduction of 3-(Methylamino)-1-phenyl-2-propen-1-one. Entry Reducing agent Isolated Yield (percent) 1 NaBH4, HOAc 77 2 Na, i-PrOH 55 [0034] The new convenient approach leading to the racemic mixture of 3-(methylamino)1-phenyl-1-propanol compliments existing methods. However, unlike some previous routes, the new method takes advantage of using one reduction step only.
55% With sodium; isopropyl alcohol In tetrahydrofuran Example 2 Reduction of 3-(Methylamino)-1-phenyl-2-propen-1-one with NaBH4 in HOAc. [0031] Acetic acid was used instead of methanol in combination with sodium borohydride under mild conditions for the reduction of 3-(methylamino)-1-phenyl-2-propen-1-one. Sodium borohydride (6 equivalents) was slowly added to a 0.25 M solution of 3-(methylamino)-1-phenyl-2-propen-1-one (Formula 3), in glacial acetic acid at 5-10° C. after stirring for 3 hours at room temperature followed by the usual work-up, the target aminoalcohol was isolated with a 77percent yield (Table 1, entry 1). The effectiveness of this method may be due to the enhanced activity of both carbonyl and azomethyne groups under acidic conditions. [0032] In a particular example, NaBH4 (800 mg, 21.0 mmol) was added in portions to a vigorously stirred solution of 3-(methylamino)-1-phenyl-2-propen-1-one (600 mg, 3.7 mmol) in glacial HOAc (15 mL) over a period of 30 min at 5-10° C. The reaction mixture was stirred for another 30 min at the same temperature, and then for 3 hours at room temperature. Work-up was done using 4 M aqueous sodium hydroxide (60 mL) that was added dropwise under water/ice bath cooling (the pH of the resulting solution was about 12). The resulting mixture was extracted with EtOAc (3.x.70 mL), washed with H2O (50 mL), and dried (Na2SO4). Evaporation of the solvent under reduced pressure gave 470 mg (77percent) of 2 as yellow oil. [0033] A similar transformation was also achieved by the use of a mixture of sodium metal (6 equiv.), isopropanol and tetrahydrofuran (Table 1, entry 2) under the conditions of the electron transfer reduction reported recently for a similar reaction of a series of enaminones. Unfortunately, the yield was only 55percent; and the reduction product contained some impurities that were difficult to remove. The new convenient approach leading to the racemic mixture of 3-(methylamino)1-phenyl-1-propanol compliments existing methods. However, unlike some previous routes, the new method takes advantage of using one reduction step only.
Reference: [1] Patent: US2004/102651, 2004, A1, . Location in patent: Page 4
[2] Patent: US2004/102651, 2004, A1, . Location in patent: Page 4
  • 3
  • [ 5409-62-1 ]
  • [ 42142-52-9 ]
Reference: [1] Patent: WO2006/37055, 2006, A1, . Location in patent: Page/Page column 21-22
  • 4
  • [ 21970-65-0 ]
  • [ 42142-52-9 ]
Reference: [1] Synthesis, 2003, # 10, p. 1626 - 1638
[2] Synthetic Communications, 2006, vol. 36, # 13, p. 1923 - 1926
  • 5
  • [ 68408-65-1 ]
  • [ 42142-52-9 ]
Reference: [1] Patent: US5892117, 1999, A,
[2] Patent: US5892117, 1999, A,
[3] Patent: US5892117, 1999, A,
[4] Patent: US5998627, 1999, A,
[5] Patent: US5998627, 1999, A,
[6] Patent: US5998627, 1999, A,
[7] Patent: US5760243, 1998, A,
[8] Patent: US5760243, 1998, A,
[9] Patent: US5760243, 1998, A,
  • 6
  • [ 18776-12-0 ]
  • [ 74-89-5 ]
  • [ 42142-52-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 10, p. 3854 - 3862
[2] Chem. Zentralbl., 1907, vol. 78, # II, p. 1086
[3] Journal of Medicinal Chemistry, 1999, vol. 42, # 16, p. 3101 - 3108
[4] Patent: WO2014/46544, 2014, A1, . Location in patent: Page/Page column 12-13; 23
  • 7
  • [ 98-86-2 ]
  • [ 42142-52-9 ]
Reference: [1] Synthetic Communications, 2006, vol. 36, # 13, p. 1923 - 1926
[2] Angewandte Chemie - International Edition, 2005, vol. 44, # 11, p. 1687 - 1689
[3] Organic Process Research and Development, 2014, vol. 18, # 7, p. 875 - 885
[4] Patent: CN103992236, 2016, B,
  • 8
  • [ 62872-58-6 ]
  • [ 74-89-5 ]
  • [ 42142-52-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 10, p. 3854 - 3862
[2] Chinese Journal of Chemistry, 2011, vol. 29, # 3, p. 504 - 510
[3] Letters in Drug Design and Discovery, 2011, vol. 8, # 3, p. 268 - 275
  • 9
  • [ 936-59-4 ]
  • [ 42142-52-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 10, p. 3854 - 3862
[2] Organic and Biomolecular Chemistry, 2011, vol. 9, # 10, p. 3854 - 3862
[3] Chinese Journal of Chemistry, 2011, vol. 29, # 3, p. 504 - 510
[4] Letters in Drug Design and Discovery, 2011, vol. 8, # 3, p. 268 - 275
  • 10
  • [ 18776-12-0 ]
  • [ 42142-52-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 10, p. 3854 - 3862
[2] Chinese Journal of Chemistry, 2011, vol. 29, # 3, p. 504 - 510
[3] Letters in Drug Design and Discovery, 2011, vol. 8, # 3, p. 268 - 275
  • 11
  • [ 108606-85-5 ]
  • [ 74-89-5 ]
  • [ 42142-52-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 32, p. 6121 - 6127
  • 12
  • [ 104-55-2 ]
  • [ 42142-52-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 32, p. 6121 - 6127
  • 13
  • [ 27152-62-1 ]
  • [ 42142-52-9 ]
Reference: [1] Chemical and pharmaceutical bulletin, 1963, vol. 11, # 8, p. 1049 - 1054
  • 14
  • [ 42142-52-9 ]
  • [ 82248-59-7 ]
Reference: [1] Patent: WO2015/1565, 2015, A2,
[2] Patent: CN106916074, 2017, A,
[3] Patent: CN108929236, 2018, A,
  • 15
  • [ 42142-52-9 ]
  • [ 455-13-0 ]
  • [ 56296-78-7 ]
Reference: [1] Patent: US2007/10678, 2007, A1, . Location in patent: Page/Page column 7
[2] Patent: WO2007/6132, 2007, A1, . Location in patent: Page/Page column 20
  • 16
  • [ 42142-52-9 ]
  • [ 98-56-6 ]
  • [ 56296-78-7 ]
YieldReaction ConditionsOperation in experiment
95.7% With hydrogenchloride; potassium hydroxide In sulfolane; water; toluene EXAMPLE 1
Preparation of N-methyl-3-[(4-trifluoromethyl)phenoxy]-3-phenyl propylamine hydrochloride (fluoxetine hydrochloride)
A mixture of N-methyl-3-hydroxy-3-phenyl propylamine (MPHA, 75 gm), potassium hydroxide (150 gm) and poly (ethylene glycol)-6000 (30 gm) was charged to sulfolane (150 ml) at 90-95° C.
Stirred and charged 1-chloro-4-trifluoromethylbenzene (90 gm) at 90-95° C.
The reaction mixture so obtained was further stirred for about 45 minutes at 120-125° C.
After the reaction was over, the reaction mixture was cooled to 20-25° C., water (990 ml) and toluene (990 ml) were added to it.
Charged hydrochloric acid (300 ml) to it slowly, stirred it vigorously, and the toluene layer was separated.
Toluene (900 ml) was recovered under vacuum at 60-65° C. to get crude fluoxetine hydrochloride and is crystallized from ethyl acetate to afford the pure product (134 gm, 95.7percent) of purity (by HPLC) more than 99percent.
Reference: [1] Patent: US2003/50508, 2003, A1,
  • 17
  • [ 42142-52-9 ]
  • [ 98-56-6 ]
  • [ 56296-78-7 ]
Reference: [1] Patent: US5225585, 1993, A,
  • 18
  • [ 42142-52-9 ]
  • [ 127-19-5 ]
  • [ 98-56-6 ]
  • [ 202122-33-6 ]
  • [ 56296-78-7 ]
Reference: [1] Organic Process Research and Development, 2014, vol. 18, # 7, p. 875 - 885
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 42142-52-9 ]

Aryls

Chemical Structure| 184845-62-3

[ 184845-62-3 ]

4-(o-tolyl)Piperidin-4-ol hydrochloride

Similarity: 0.86

Chemical Structure| 56613-81-1

[ 56613-81-1 ]

(S)-2-Amino-1-phenylethanol

Similarity: 0.79

Chemical Structure| 2549-14-6

[ 2549-14-6 ]

(R)-2-Phenylglycinol

Similarity: 0.79

Chemical Structure| 65214-86-0

[ 65214-86-0 ]

4-Diphenylmethoxypiperidine hydrochloride

Similarity: 0.78

Chemical Structure| 51096-49-2

[ 51096-49-2 ]

(S)-2-Benzylamino-1-phenylethanol

Similarity: 0.77

Alcohols

Chemical Structure| 184845-62-3

[ 184845-62-3 ]

4-(o-tolyl)Piperidin-4-ol hydrochloride

Similarity: 0.86

Chemical Structure| 56613-81-1

[ 56613-81-1 ]

(S)-2-Amino-1-phenylethanol

Similarity: 0.79

Chemical Structure| 2549-14-6

[ 2549-14-6 ]

(R)-2-Phenylglycinol

Similarity: 0.79

Chemical Structure| 51096-49-2

[ 51096-49-2 ]

(S)-2-Benzylamino-1-phenylethanol

Similarity: 0.77

Chemical Structure| 23396-50-1

[ 23396-50-1 ]

3-Phenylpiperidin-3-ol

Similarity: 0.76

Amines

Chemical Structure| 56613-81-1

[ 56613-81-1 ]

(S)-2-Amino-1-phenylethanol

Similarity: 0.79

Chemical Structure| 2549-14-6

[ 2549-14-6 ]

(R)-2-Phenylglycinol

Similarity: 0.79

Chemical Structure| 51096-49-2

[ 51096-49-2 ]

(S)-2-Benzylamino-1-phenylethanol

Similarity: 0.77

Chemical Structure| 114843-08-2

[ 114843-08-2 ]

3-Amino-1-phenylpropan-1-ol oxalate

Similarity: 0.75

Chemical Structure| 29194-04-5

[ 29194-04-5 ]

2-(Benzyl(methyl)amino)-1-phenylethanol

Similarity: 0.74